Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis

American Journal of Physiology - Heart and Circulatory Physiology - Tập 305 Số 9 - Trang H1373-H1381 - 2013
Marco Guazzi1, Francesco Bandera2, Gabriele Pelissero2, Serenella Castelvecchio2, Lorenzo Menicanti3, Stefano Ghio4, Pier Luigi Temporelli5, Ross Arena6
1Heart Failure Unit, Department of Cardiology, University of Milano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato, Milano, Italy;
21Heart Failure Unit, Department of Cardiology, University of Milano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato, Milano, Italy;
32Department of Cardiosurgery, IRCCS Policlinico San Donato, Milano, Italy;
43Department of Cardiology, Fondazione IRCCS Policlinico San Matteo, University Hospital, Pavia, Italy;
5Fondazione “Salvatore Maugeri,” IRCCS, Veruno, Italy; and
65Department of Physical Therapy, College of Applied Health Sciences, University of Illinois Chicago, Chicago, Illinois

Tóm tắt

Echo-derived pulmonary arterial systolic pressure (PASP) and right ventricular (RV) tricuspid annular plane systolic excursion (TAPSE; from the end of diastole to end-systole) are of basic relevance in the clinical follow-up of heart failure (HF) patients, carrying two- to threefold increase in cardiac risk when increased and reduced, respectively. We hypothesized that the relationship between TAPSE (longitudinal RV fiber shortening) and PASP (force generated by the RV) provides an index of in vivo RV length-force relationship, with their ratio better disclosing prognosis. Two hundred ninety-three HF patients with reduced (HFrEF, n = 247) or with preserved left ventricular (LV) ejection fraction (HFpEF, n = 46) underwent echo-Doppler studies and N-terminal pro-brain-type natriuretic peptide assessment and were tracked for adverse events. The median follow-up duration was 20.8 mo. TAPSE vs. PASP relationship showed a downward regression line shift in nonsurvivors who were more frequently presenting with higher PASP and lower TAPSE. HFrEF and HFpEF patients exhibited a similar distribution along the regression line. Given the TAPSE, PASP, and TAPSE-to-PASP ratio (TAPSE/PASP) collinearity, separate Cox regression and Kaplan-Meier analyses were performed: one with TAPSE and PASP as individual measures, and the other combining them in ratio form. Hazard ratios for variables retained in the multivariate regression were as follows: TAPSE/PASP </≥ 0.36 mm/mmHg [hazard ratio (HR): 10.4, P < 0.001]; TAPSE </≥ 16 mm (HR: 5.1, P < 0.01); New York Heart Association functional class </≥ 3 (HR: 4.4, P < 0.001); E/e’ (HR: 4.1, P < 0.001). This study shows that the TAPSE vs. PASP relationship is shifted downward in nonsurvivors with a similar distribution in HFrEF and HFpEF, and their ratio improves prognostic resolution. The TAPSE vs. PASP relationship as a possible index of the length-force relationship may be a step forward for a more efficient RV function evaluation and is not affected by the quality of LV dysfunction.

Từ khóa


Tài liệu tham khảo

Abel FL, 1967, J Thorac Cardiovasc Surg, 54, 886, 10.1016/S0022-5223(19)43030-4

10.7326/0003-4819-116-11-888

10.1136/hrt.78.5.480

10.1016/j.jacc.2011.06.076

Chesler NC, 2009, Conf Proc IEEE Eng Med Biol Soc, 2009, 177

10.1016/j.cardfail.2011.12.003

10.1093/eurjhf/hfp111

10.1093/eurheartj/ehs080

10.1016/S0008-6363(96)88618-4

10.1016/j.ahj.2007.03.033

10.1016/j.ejheart.2008.04.003

10.1152/ajpheart.00286.2006

10.1164/rccm.200604-547OC

10.1067/mhj.2003.146

10.1016/S0735-1097(00)01102-5

10.1016/S0002-9149(99)00877-2

10.1093/eurjhf/hfs208

10.1016/j.healun.2006.06.015

10.1152/ajpheart.00866.2007

10.1161/CIRCULATIONAHA.111.085761

10.1183/09059180.00004612

10.1016/j.amjcard.2009.01.024

10.1183/09031936.00078411

10.1136/hrt.2010.212084

10.1016/0002-9149(90)90711-9

10.1016/j.ejheart.2007.03.001

10.1016/j.jacc.2008.11.051

10.1016/j.amjcard.2010.02.039

10.1161/CIRCULATIONAHA.109.887570

10.1016/j.echo.2010.05.010

10.1016/j.amjcard.2007.07.064

10.1093/eurheartj/ehr490